The NanoCHIP® GIP (Gastrointestinal Panels) assays performed on the NanoCHIP® platform, is an automated qualitative in vitro diagnostic test for the direct detection and differentiation of human diarrheal bacteria and parasites in stool specimens from symptomatic patients.
Infectious gastroenteritis is one of the most common diseases worldwide. Estimation has been made in which about 3.5 billion people are affected, and that 450 million are ill as a result of these infections, the majority being children. Transmission of intestinal parasites and enteropathogenic bacteria is characterized as fecal-oral human-to-human transmission.
Diarrhea diseases are widely common in developed as well as developing countries and are major causes of morbidity and mortality, affecting millions of individuals each year. The etiologies of diarrhea include viruses (e.g., Norwalk-like viruses, rotaviruses, and enteric adenoviruses), bacteria (e.g., Campylobacter, Shigella, Salmonella, and cytotoxigenic Clostridium difficile), and parasites (e.g., Entamoeba histolytica, Giardia lamblia, Dientamoeba fragilis, Blastocystis hominis and Cryptosporidium spp.).
Savyon offers several test panel for differential diagnostics of up to 12 pathogenic bacteria and parasites:
| Catalog No | Product name | Tests/kit | Approvals |
| 899051 | NanoChip Gastrointestinal Panel Combi I | 78 | CE |
| 899057 | NanoChip Gastrointestinal Panel Combi II | 96 | CE |
| 899052 | NanoChip Gastrointestinal Parasites Panel I | 131 | CE |
| 899053 | NanoChip Gastrointestinal Bacteria Panel 1 | 131 | CE |